¿Cómo afectan diferentes TME la respuesta a la vacuna contra la COVID-19 de las personas?
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.